Fiona See, Ph.D., postdoctoral research fellow in the laboratory of Dr. Silviu Itescu, M.B., B.S., will present two groundbreaking abstracts on repairing damage from heart failure with stem cells at AHA this year.
Mark Russo, M.D., M.S., a researcher at Columbia University’s International Center for Health Outcomes and Innovation Research in New York will present findings from a study of the cost of medical management in chronic end-stage heart failure patients. The study found that despite the terminal nature of end-stage heart failure, costs and resource utilization increased dramatically as death approached.
Mario Deng, MD, assistant professor of Medicine in the division of Cardiology and director of the Cardiac Transplantation Research at Columbia University Medical Center, will present his laboratory’s research on the relationship between genes and the rejection of transplanted hearts.
UCLA researchers report that although the majority of medical journals have conflict of interest policies in place for study authors, less than half require such policies for editors or peer-reviewers. In addition, many journals do not inform readers about those potential conflicts that have been disclosed to them.
A new lab-on-a-chip can identify single bacterial cells for the most common cases of drug-resistant pneumonia, cutting down the wait from days to hours for identifying the particular strain and treating it.
Results of the two largest studies on hyponatremia, SALT-1 and SALT-2, presented Nov. 14 at the American Heart Association’s Scientific Sessions in Chicago, found that the investigational drug tolvaptan treated hyponatremia ? water intoxication — faster and more effectively than available treatments.
Global warming has already caused extinctions in the most sensitive habitats and will continue to cause more species to go extinct over the next 50 to 100 years, confirms the most comprehensive study since 2003 on the effects of climate change on wild species worldwide by a University of Texas at Austin biologist.
An international group of researchers has identified genes which enable the maize smut pathogen to live as a parasite.
Researchers at the Johns Hopkins’ High Throughput Biology Center have invented two new gene “chip” technologies that can be used to help identify otherwise elusive disease-causing mutations in the 97 percent of the genome long believed to be “junk.”
Swiss researchers led by R. Zenobi have developed a mass-spectrometric method to quickly and easily obtain a proper fingerprint of breath, including the quantitative detection of large, nonvolatile compounds. Breath analysis has some advantages for clinical diagnosis, for example it requires no puncture.